[Form 4] Vicarious Surgical Inc. Insider Trading Activity

Rhea-AI Filing Summary

Khalifa Sammy, identified as a director, a 10% owner and Chief Technology Officer of Vicarious Surgical Inc. (RBOT), reported an equity award on 06/27/2025. The filing shows acquisition of 25,025 stock options with an exercise price of $7.61. The options vest in 48 equal monthly installments beginning on the one-month anniversary of the grant, tying vesting to continued service. The options appear to carry a term that ends on 06/26/2035, and the number of derivative securities beneficially owned following the transaction is 25,025. The form is signed by an attorney-in-fact on 08/11/2025.

Positive

• Khalifa Sammy, a director and CTO, acquired 25,025 stock options, demonstrating management alignment with shareholder value
• Options vest in 48 equal monthly installments, which supports long-term retention and performance incentives
• Exercise price is $7.61 with an apparent expiration date of 06/26/2035, providing a standard long-term exercise window

Negative

• None.

Insights

Financial Analyst

TL;DR: Insider option grant aligns senior management with long-term performance but size relative to share base is not disclosed.

The reported grant to Khalifa Sammy creates a multi-year incentive through 25,025 options at a $7.61 strike vesting monthly over four years. Such schedules encourage retention and link compensation to long-term share performance. Without information on outstanding shares or immediate vesting, the market impact and dilution cannot be quantified from this filing alone. The 10-year apparent term to 06/26/2035 is standard for equity grants and provides a long runway for potential exercise.

Corporate Governance Expert

TL;DR: Grant to a director/CTO is a routine governance action but requires disclosure context to assess materiality.

As both a director and an officer, Khalifa Sammy receiving an award is consistent with compensation practices for senior executives. The 48-month monthly vesting indicates a retention-focused design. The Form 4 properly discloses relationship, transaction date (06/27/2025), and post-transaction ownership (25,025 options). Materiality for shareholders depends on total share count and prior holdings, which are not provided here.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Khalifa Sammy

(Last) (First) (Middle)

C/O VICARIOUS SURGICAL INC.

78 FOURTH AVENUE

(Street)

WALTHAM MA 02451

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Vicarious Surgical Inc. [ RBOT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Technology Officer

3. Date of Earliest Transaction (Month/Day/Year)
06/27/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$7.61	06/27/2025		A		25,025		(1)	06/26/2035	Class A Common Stock	25,025	$0.00	25,025	D

Explanation of Responses:

1. The shares underlying this option vest in 48 equal monthly installments beginning on the one-month anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date.

	/s/ Erin Checka, Attorney-in-Fact	08/11/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction was reported for Vicarious Surgical (RBOT)?

The Form 4 reports the acquisition of 25,025 stock options by Khalifa Sammy on 06/27/2025.

Who is the reporting person on the RBOT Form 4?

The reporting person is Khalifa Sammy, identified as a Director, 10% owner, and Chief Technology Officer.

What are the key terms of the options granted to the RBOT insider?

The options have an exercise price of $7.61, vest in 48 equal monthly installments beginning one month after grant, and show an apparent expiration of 06/26/2035.

How many derivative securities does the reporting person own after the transaction?

The filing reports 25,025 derivative securities beneficially owned following the transaction.

When was the Form 4 signed?

The signature on the filing is dated 08/11/2025, signed by Erin Checka as attorney-in-fact.